Should low-risk DCIS lose the cancer label? An evidence review

ConclusionEpidemiological evidence supports consideration of relabelling and/or recalibrating diagnostic thresholds for low-risk DCIS. Such diagnostic changes would need agreement on the definition of low-risk DCIS and improved diagnostic reproducibility.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research